{"transactions":[{"id":4640756,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22764,"kind":"person","name":"Meluzio Michael Vincent","position":1,"cik":"0002138368","reported_name":"Meluzio Michael Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Prin. Accounting Officer"}}],"security":"Common Stock","published_at":"2026-10-15T01:38:15.000Z","date":"2026-10-12","kind":"sale","planned":false,"acquired":false,"shares":1144,"price":28.05,"value":32089.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represent shares sold pursuant to the Issuer's Company-Wide Policy and do not represent discretionary transactions by the Reporting Person. These sales were made automatically to satisfy mandatory tax withholding obligations through a \"sell-to-cover\" transaction in connection with the vesting and settlement of restricted stock units, and the Reporting Person did not exercise any control over the timing, price or number of shares sold."}],"balance_after":47817,"source":{"system":"sec-edgar","filing":"0002138368-26-000009","document":"form4-10152026_011010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2138368/000213836826000009/form4-10152026_011010.xml","form_type":"4"}},{"id":685122,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22764,"kind":"person","name":"Meluzio Michael Vincent","position":1,"cik":"0002138368","reported_name":"Meluzio Michael Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Prin. Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:19:56.000Z","date":"2026-08-13","kind":"exercise","planned":false,"acquired":false,"shares":13647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The performance stock units (\"PSU\") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The performance stock units (\"PSU\") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The performance stock units (\"PSU\") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days."}],"balance_after":27295,"derivative":{"underlying":"Common Stock","underlying_shares":13647},"source":{"system":"sec-edgar","filing":"0002138368-26-000007","document":"form4-08172026_100852.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000213836826000007/form4-08172026_100852.xml","form_type":"4"}},{"id":685121,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22764,"kind":"person","name":"Meluzio Michael Vincent","position":1,"cik":"0002138368","reported_name":"Meluzio Michael Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Prin. Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:19:56.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":3,"price":31.13,"value":93.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell-to-cover\" transaction and do not represent discretionary transactions by the reporting person."}],"balance_after":48961,"source":{"system":"sec-edgar","filing":"0002138368-26-000007","document":"form4-08172026_100852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000213836826000007/form4-08172026_100852.xml","form_type":"4"}},{"id":685120,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22764,"kind":"person","name":"Meluzio Michael Vincent","position":1,"cik":"0002138368","reported_name":"Meluzio Michael Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Prin. Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:19:56.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":4106,"price":30.35,"value":124617.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell-to-cover\" transaction and do not represent discretionary transactions by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $29.99 to $30.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades."}],"balance_after":48964,"source":{"system":"sec-edgar","filing":"0002138368-26-000007","document":"form4-08172026_100852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000213836826000007/form4-08172026_100852.xml","form_type":"4"}},{"id":685119,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22764,"kind":"person","name":"Meluzio Michael Vincent","position":1,"cik":"0002138368","reported_name":"Meluzio Michael Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Prin. Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:19:56.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":1519,"price":29.37,"value":44613.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell-to-cover\" transaction and do not represent discretionary transactions by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $28.97 to $29.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades."}],"balance_after":53070,"source":{"system":"sec-edgar","filing":"0002138368-26-000007","document":"form4-08172026_100852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000213836826000007/form4-08172026_100852.xml","form_type":"4"}},{"id":685118,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22764,"kind":"person","name":"Meluzio Michael Vincent","position":1,"cik":"0002138368","reported_name":"Meluzio Michael Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Prin. Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-17T22:19:56.000Z","date":"2026-08-13","kind":"exercise","planned":false,"acquired":true,"shares":13647,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":54589,"source":{"system":"sec-edgar","filing":"0002138368-26-000007","document":"form4-08172026_100852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000213836826000007/form4-08172026_100852.xml","form_type":"4"}},{"id":711017,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22764,"kind":"person","name":"Meluzio Michael Vincent","position":1,"cik":"0002138368","reported_name":"Meluzio Michael Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Prin. Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-10T23:34:24.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":40942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents the grant of performance stock units (\"PSUs\"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the grant of performance stock units (\"PSUs\"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the grant of performance stock units (\"PSUs\"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration."}],"balance_after":40942,"derivative":{"underlying":"Common Stock","underlying_shares":40942},"source":{"system":"sec-edgar","filing":"0002138368-26-000005","document":"form4-07102026_110720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000213836826000005/form4-07102026_110720.xml","form_type":"4"}},{"id":711016,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":22764,"kind":"person","name":"Meluzio Michael Vincent","position":1,"cik":"0002138368","reported_name":"Meluzio Michael Vincent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Prin. Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-10T23:34:24.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":40942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents that grant of restricted stock units (\"RSUs\").  The shares subject to the RSUs vest in equal quarterly installments over a period of forty-eight (48) months, measured from the date of grant, subject to the reporting person's continued service with the issuer through each vest date."}],"balance_after":40942,"source":{"system":"sec-edgar","filing":"0002138368-26-000005","document":"form4-07102026_110720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000213836826000005/form4-07102026_110720.xml","form_type":"4"}}]}